Make medicines affordable - without going to court

11 July 2023 - Governments can and must take control to prevent extreme drug prices. ...

Read more →

Dutch Ministry Of Health will not reimburse Gilead’s breast cancer drug, Trodelvy

1 May 2023 - Last month, the Dutch Ministry of Health, Welfare and Sport (VWS) announced that it will not ...

Read more →

Anti-viral COVID-19 treatment now available in the Netherlands for 1,250 Euros

1 December 2022 - The anti-viral medication approved to treat COVID-19 is now available on the Dutch market, the Dutch Association ...

Read more →

High demand of popular obesity drug Saxenda; may be going to "wrong" patients

26 November 2022 - Since April of this year there has been a high demand for the obesity drug Saxenda, but ...

Read more →

Amryt receives reimbursement approval from the Dutch Ministry of Health for Myalepta (metreleptin)

17 October 2022 - Amryt receives reimbursement approval from the Dutch Ministry of Health for Myalepta (metreleptin). ...

Read more →

Patients in the Netherlands wait 1.5 years for access to new medicines

2 September 2021 - Patients in the Netherlands have to wait an average of 510 days for access to a new ...

Read more →

Hansa Biopharma announces reimbursement in the Netherlands of Idefirix (imlifidase) as desensitisation treatment for highly sensitised kidney transplant patients

2 August 2021 - Idefiris (imlifidase) for enabling kidney transplantation in highly sensitised patients is now reimbursable and available for use ...

Read more →

Dutch advisory group says Zolgensma shouldn’t be covered unless Novartis halves price

10 May 2021 - In a challenge to Novartis, a Dutch advisory body has recommended that the government not cover ...

Read more →

World’s most expensive drug may not be covered by Dutch insurance

7 May 2021 - A drug to treat a rare muscle disease which affects some 20 children in the Netherlands ...

Read more →

Celltrion’s Remsima SC launches in Netherlands

7 May 2020 - Subcutaneous rheumatoid arthritis treatment Remsima SC launched in the Netherlands, its third European market, Celltrion Healthcare ...

Read more →

Conditional financing of drugs in the Netherlands: past, present, and future—results from stakeholder interviews

8 April 2019 - It is long known that managed entry agreements may offer decision makers valuable policy options to ...

Read more →

AbbVie's massive Humira discounts are stifling Netherlands biosimilars

2 April 2019 - Could a drug's price ever be too low? That’s what some market-watchers are asking in the ...

Read more →

Better together when buying medicines? Taking stock of the BeNeLuxA initiative

11 December 2018 - With Ireland being the latest to join in June 2018, there is clearly interest in the ...

Read more →

Cystic fibrosis patients may take state to court over medicine funding

18 October 2017 - A lobby group for people suffering from cystic fibrosis is considering taking legal action against the ...

Read more →